Browse News
Filter News
Found 521,706 articles
-
A new service offered by a pair of New York-based companies, H1 and Innovatively, is being touted as a tool that can help life science companies cut the time it takes to take a product through the clinic and into market in half.
-
Recently, 23andMe partnered with GlaxoSmithKline, causing the Forbes Technology Council to cite eight ways these types of partnerships will affect disease treatments. These types of partnerships aren’t exactly new.
-
First impressions matter, and during your first few weeks at your new job, you’re laying the groundwork and establishing those key working relationships and processes that will set you up for success in the long run.
-
SI-BONE Announces Pricing of Initial Public Offering at $15.00 per share
10/17/2018
SI-BONE, Inc. today announced the pricing of its initial public offering of 7,200,000 shares of common stock at a price to the public of $15.00 per share.
-
Canopy Growth Introduces LBS Brand to Canada
10/17/2018
Canopy Growth Corporation is pleased to announce the launch of a new brand for the recreational market in Canada, LBS
-
MedPharm Awarded Colorado’s First Cannabis Research License
10/17/2018
MedPharm announced today that it has been awarded the first cannabis research license by the state of Colorado.
-
Canopy Growth Celebrates History and the Legalization of Recreational Cannabis in Canada
10/17/2018
Canopy Growth Corporation is pleased to join Canadians and cannabis advocates from around the world in celebrating today's legalization of recreational cannabis in Canada.
-
Two well-established pharma companies are expanding in two different U.S. cities. One city is known for the plethora of pharma and biotech jobs, while the other is in an area that might not immediately spring to mind when it comes to biotech hubs.
-
Discovery Life Sciences, a leading research biobank located in Los Osos, California, recently got much, much bigger via a four-company merger. Ann Dover, Discovery’s founder, president and CEO, took time to speak with BioSpace about the merger and the new identity of the company.
-
“President Trump is taking historic action to bring patients more transparency through consumer advertising,” Azar said in a speech. “We are proposing to require American drug companies for the first time ever to include in their TV advertising the list prices of drugs paid for by Medicare or Med...
-
Among life on earth, mammals are some of the only creatures that can’t regenerate damaged hearing. Birds, frogs, fish, they all have the ability to regenerate sensory hair cells after they’re damaged.
-
Taiho Ventures, the corporate venture capital arm of Taiho Pharmaceutical, has pumped up its venture capital pool from $50 million to $300 million. It also indicates it plans to accelerate its “open innovation” through the investments.
-
AbbVie’s Humira is the world’s best-selling drug that generated more than $18 billion for the Illinois-based company last year. This week though, the company will begin to see challenges to Humira in Europe from biosimilars developed by Amgen and Novartis, as well as others.
-
New data from an ongoing late-stage study reinforced the safety and efficacy of Cosentyx (secukinumab) as a beneficial treatment for patients with psoriatic arthritis and ankylosing spondylitis.
-
Again and again … and again, drugs have failed in clinical trials for Alzheimer’s disease. According to a new report, in the last decade, 146 drugs have failed in clinical trials for Alzheimer’s.
-
In the workplace, it’s possible to have too much of a good thing. There is a delicate balance between having a positive mindset and being overly optimistic.
-
12 Ways to Research a Potential New Employer
10/16/2018
Whether you’re doing pre-interview research or you’ve already received a job offer and are deciding whether or not to accept it, the research phase of your job search is perhaps the most critical from a job seeker's perspective. -
MERGER CREATES NEW GLOBAL LEADER IN BIOSPECIMEN SOLUTIONS: FOUR COMPANIES UNITE TO FORM DISCOVERY LIFE SCIENCES
10/16/2018
Conversant Bio, Folio Bio, Discovery Life Sciences and Phylogeny announced today that they have merged under the name Discovery Life Sciences™ (Discovery) to create a global market leader in biospecimen analysis and procurement for the pharmaceutical, biotechnology and diagnostics industries.
-
Johnson & Johnson Reports 2018 Third-Quarter Results:
10/16/2018
2018 Third-Quarter Sales of $20.3 Billion Increased 3.6% versus 2017
-
Mallinckrodt To Present At 2018 Jefferies London Healthcare Conference
10/16/2018
Mallinckrodt Pharmaceuticals will present on Wednesday, Nov. 14, 2018, at the Jefferies London Healthcare Conference in London.